Blue Horseshoe Stocks: NFLX, BANC Updates & More

Netflix, Inc. NFLX – Update

Our NFLX options ideas from Tuesday morning continued to provide us with excellent intraday gains to take advantage of yesterday, despite already logging moves ranging between 54-98%.  Our target range, the NFLX Weekly $117-120 Calls, once again put up fantastic performances, regardless of which strike point was chosen.

Here are the total possible gains for yesterday’s session:

$117 Calls – Range: 2.19-5.59 – Max Gain: 155%
$118 Calls – Range: 1.43-4.70 – Max Gain: 229%
$119 Calls – Range: 1.03-3.87 – Max Gain: 276%
$120 Calls – Range: 1.07-3.09 – Max Gain: 189%

We’ve had a nice two-day run with these contracts and are ready to move on to the next idea, unless we see a dip-and-rip setup on the chart, in which case they would come back into play.
_____

Banc of California  BANC Update

Our other options idea from yesterday also worked out in spades. We noticed that the stock had been absolutely abused on immaterial news the session prior, and took the chance to pounce with  a signal on the stock for a possible bottom play, and both short and mid-term options ideas.

Those were the BANC Weekly $12.50 and $15 Calls and the BANC 11/18 $17.50 and $20 Calls, and with the exception of the $20’s which are still too far out of the money to have seen any appreciable upswing, they all did rather well.

Weekly $12.50 Calls – Range: .55-1.40 – Max Gain: 155%
Weekly $15 Calls – Range: .05-.25 – Max Gain: 400%
11/18 $17.50 Calls – Range: .15-.35 – Max Gain: 133%

With the stock appearing to gear up for another solid session, those 11/18 $20 Calls could join the rest of the group in making moves for us in upcoming sessions, so we’ll continue to keep a close watch.
______

Fresh Idea – American Express Co. AXP

We’ve got another post-earnings options idea to add into the mix this morning as well with American Express, which beat expectations and raised guidance on profits for the remainder of 2016. Accordingly, we’re going to want to track AXP Weekly $64-65.50 Calls.


Cannabis Stock Updates

Cannabis Science, Inc. CBIS – CBIS continued to push to new highs after our flag of the stock on Tuesday. After running 44% that day from .034 to .0489, we saw another solid round of gains yesterday. The stock traded in a range from .049 to .077, for a 57% intraday run and an overall increase of 126% over Tuesday’s low.

_____

IMD Companies, Inc. ICBU – Also among the marijuana stocks that we’ve slated for observation was this one that was new to our reports yesterday, and put up a pretty good move for our first day of observance.

ICBU traded up from a morning low of .0039 and surged to .0056, for an intraday pop of 44%


Plandai Biotechnology, Inc. PLPL

Being added to the watchlist this morning is PLPL, as a momentum play. The stock has been on the move over the past couple of sessions, having cracked through key resistance points on heavy volume. If it can breach the 200DMA of .045, things could get even more interesting from here.

We’ll remain interested in this play provided it can hold support at or above .03 on any pullbacks.
.


Extended Watchlist:
AXPW, PNTV, MYEC, ENDO, DAN

Afternoon Update on Plandai Biotech (PLPL)

Plandai Biotechnology, Inc. PLPL
We’re sending out an update on PLPL this afternoon following this morning’s report. After trading as low as .55, the stock made its way back to .67, registering a 22% intraday gain in the process, and is currently holding support above the 50DMA.
In addition to an opportunity for a tidy profit during early trading, PLPL provided the public with a new press release that you can check out below. It eludes to an intellectual property licensing agreement, under the terms of which the company should be able to increase the effectiveness of its botanical extracts by a significant margin.

SEATTLE, WA, September 3, 2013 – (ACCESSWIRE) – Plandai Biotechnology, Inc. (PLPL), a producer of highly bioavailable plant extracts for industries including health, wellness, nutriceutical, and pharmaceutical, today announced that it has signed an exclusive agreement with North-West University in Potchefstroom, South Africa, that holds the patents and associated intellectual property associated with the entrapment of compounds in long-chain fatty acids-based nano- and micro-particles, known as Pheroid(R). Under the terms of the world license, Plandai has the exclusive right to use the Pheroid(R) technology with all Phytofare polyene-based extracts, which includes proprietary extracts of most botanical matter, for human and animal use. >>> FULL PR


Some links for those who may have missed this morning’s newsletter:
PLPL Report
PLPL Video Chart


Extended Watchlist:
RENU, IWEB, LTCHD, NOK

Plandai Biotechnology, Inc. | PLPL | Added to Watchlist

Plandai Biotechnology, Inc. PLPL

Good morning traders, we hope everyone had an enjoyable long weekend. We’re bringing a new stock into the mix this morning in the agricultural/biotechnology business. The company’s main holding consists of an 8000+ acre plantation located in Mpumalanga, South Africa (2000 acres of which are used for production of green tea), and a recent licensing and raw-material provision agreement has it aligned with Phyto Nutricare.

This partnership will facilitate the delivery of Phytofare™ branded botanical extracts and nutraceuticals to the international marketplace. Some of the highlights of the Phytofare line include:

  • Patented Formula – The products are a result of years of research into plant extracts.
  • Consist of extracts taken from LIVING plant material, setting Phytofare™ apart.
  • Improved integration into bloodstream, known as “bio-availability” (More on that below)
  • Contain Nano-Sized Particles for maximum cell permeability.
  • Unique Isomeric Properties (Isomers are particles with the same molecular properties as a given element, while having different chemical properties.)

Plandai, through Phytofare™, has a chance at making a real dent in the green tea extract market. Currently, even high-purity green tea extracts on today’s market have been tested and found to be lacking in bio-availability, that is only a small amount (≤10%) of the essential nutrients are absorbed into the system. However, in USDA tests, Phytofare extracts have demonstrated improved bio-availability levels to as much as 60-80% which obviously is a dramatic increase in potency.

This apparent leap forward in green tea extract technology should allow PLPL to make its mark on the cosmeceutical, health & wellness, as well as the food & beverage industries. After all, who among current green tea extract consumers wouldn’t want the benefit of the same products they’ve come to appreciate having exponentially increased effectiveness? For this reason, we’re anxious to include PLPL on our watchlists moving forward.


We’ve also prepared a video of the PLPL chart to point out some of the highlights:

Additionally, the good folks over at BARCHART.COM currently give PLPL a 72% Overall “Buy” Rating, Including a 100% Rating on Long-Term Indicators.


More Info @

http://www.plandaibiotech.com/